Ohio and Indiana are suing the makers of a popular heartburn medication, saying the drug company concealed cancer risks and cost investors billions.

German scientist Paul Ehrlich introduced a groundbreaking concept to the world: chemical compounds could be engineered to interact ...

Fear returned to the world’s stock markets today after Donald Trump’s swingeing new “Liberation Day” tariffs came into force.

GSK is paying to access ABL Bio’s Grabody-B platform, which potentially enables therapies to cross the blood-brain barrier.

NEW YORK CITY, NY / ACCESS Newswire / April 7, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...

Me, one of the first companies to provide direct-to-consumer genetic testing kits, has filed for bankruptcy. Since its ...

As an incentive, Fairfield approved a community reinvestment area agreement with both companies. It provides a 5-year, 45 ...

according to GSK. Antimicrobial resistance, where bacteria withstand the drugs designed to kill them, results in over 2.8 million infections annually in the United States, according to the CDC.

Its development was funded in part by grants from the US government's Biomedical Advanced Research and Development Authority ...

(Alliance News) - GSK on Tuesday said its urinary tract infection treatment gepotidacin, under the brand name Blujepa, has been approved in the US. The London-based pharmaceuticals company said ...

The pharma industry has been left reeling by the recent news of US government trade tariffs ... reshoring the company’s small molecule API production. The fourth location will extend Lilly’s ...

When asked, some like Cisco and SAS gave general hiring ranges; others like IBM and GlaxoSmithKline declined to share location-specific jobs figures at all. But while employers don’t have to ...